Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies
Year: 2019
Type: conference-abstract
Abstract: The 2015 Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference presented major challenges in achieving equitable access to affordable medicines not just in low-and middle-income countries but in high-income countries as well.This included innovative medicines such as sofosbuvir whose planned market entry hit public payers of high-income countries unprepared.As further new medicines with high prices were expected to come to the market in the future, the "sofosbuvir case" can be seen as a kind of "wake-up" call.Apart from high-priced medicines that dramatically challenge the sustainability of pharmaceutical systems, discussions at the 2015 PPRI Conference included non-availability of effective low-priced medicines, critical assessment of the intended and unintended effects of existing policies and supportive tools such as cost-effectiveness analysis as well as limitations related to transparency in medicine price information [1].Local challenges, global learnings?Compared to previous years, the 2015 debate was characterized by the fact that all countries, including rich economies, were struggling to ensure affordable medicine access to their citizens.Promoting affordable medicines used to be an individual fight, since pharmaceutical policies for procuring, pricing and funding medicines are national competenceeven in the countries of
Authors: Elisa Guidotti, Bruna Vinci, Francesco Attanasio, Federico Vola
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
SDG: Reduced inequalities
Open Access status: gold
Estimated APC paid: $2,290
OpenAlex ID: W3005602724